Literature DB >> 25670707

A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture.

Indra Bergval1, Francesc Coll2, Anja Schuitema3, Hans de Ronde3, Kim Mallard2, Arnab Pain4, Ruth McNerney2, Taane G Clark2, Richard M Anthony3.   

Abstract

We studied genomic variation in a previously selected collection of isogenic Mycobacterium tuberculosis laboratory strains subjected to one or two rounds of antibiotic selection. Whole genome sequencing analysis identified eleven single, unique mutations (four synonymous, six non-synonymous, one intergenic), in addition to drug resistance-conferring mutations, that were fixed in the genomes of six monoresistant strains. Eight loci, present as minority variants (five non-synonymous, three synonymous) in the genome of the susceptible parent strain, became fixed in the genomes of multiple daughter strains. None of these mutations are known to be involved with drug resistance. Our results confirm previously observed genomic stability for M. tuberculosis, although the parent strain had accumulated allelic variants at multiple locations in an antibiotic-free in vitro environment. It is therefore likely to assume that these so-called hitchhiking mutations were co-selected and fixed in multiple daughter strains during antibiotic selection. The presence of multiple allelic variations, accumulated under non-selective conditions, which become fixed during subsequent selective steps, deserves attention. The wider availability of 'deep' sequencing methods could help to detect multiple bacterial (sub)populations within patients with high resolution and would therefore be useful in assisting in the detailed investigation of transmission chains. © FEMS 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  MDR-TB; drug resistance; evolution; mutation; tuberculosis; whole genome sequencing

Mesh:

Substances:

Year:  2014        PMID: 25670707     DOI: 10.1093/femsle/fnu037

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  4 in total

1.  A New Natural Product Analog of Blasticidin S Reveals Cellular Uptake Facilitated by the NorA Multidrug Transporter.

Authors:  Jack R Davison; Katheryn M Lohith; Xiaoning Wang; Kostyantyn Bobyk; Sivakoteswara R Mandadapu; Su-Lin Lee; Regina Cencic; Justin Nelson; Scott Simpkins; Karen M Frank; Jerry Pelletier; Chad L Myers; Jeff Piotrowski; Harold E Smith; Carole A Bewley
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineages.

Authors:  Jody E Phelan; Francesc Coll; Indra Bergval; Richard M Anthony; Rob Warren; Samantha L Sampson; Nicolaas C Gey van Pittius; Judith R Glynn; Amelia C Crampin; Adriana Alves; Theolis Barbosa Bessa; Susana Campino; Keertan Dheda; Louis Grandjean; Rumina Hasan; Zahra Hasan; Anabela Miranda; David Moore; Stefan Panaiotov; Joao Perdigao; Isabel Portugal; Patricia Sheen; Erivelton de Oliveira Sousa; Elizabeth M Streicher; Paul D van Helden; Miguel Viveiros; Martin L Hibberd; Arnab Pain; Ruth McNerney; Taane G Clark
Journal:  BMC Genomics       Date:  2016-02-29       Impact factor: 3.969

3.  Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.

Authors:  P A Black; M de Vos; G E Louw; R G van der Merwe; A Dippenaar; E M Streicher; A M Abdallah; S L Sampson; T C Victor; T Dolby; J A Simpson; P D van Helden; R M Warren; A Pain
Journal:  BMC Genomics       Date:  2015-10-24       Impact factor: 3.969

4.  Nationwide distribution of varicella-zoster virus clades in China.

Authors:  Songtao Xu; Mukai Chen; Huanying Zheng; Haiyan Wang; Meng Chen; Jianhui Zhou; Wang Shuang; Pengbo Yu; Chaofeng Ma; Jilan He; Daxing Feng; Zhu Zhen; Zhang Yan; Mao Naiying; Aili Cui; Qiuhua Wu; Mengyuan Qi; Chongshan Li; Xiaoguang Xu; Wenbo Xu
Journal:  BMC Infect Dis       Date:  2016-10-07       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.